EPC328 Linking PLHIV lost to follow-up back to care in 5 regions of the Russian FederationE-posterMeasuring and enhancing retention and adherence in HIV prevention programmes
EPC329 Improving viral load testing uptake for HIV infected cohort on antiretroviral therapy (ART) at a rural setting: lessons learnt from Neno district, MalawiE-posterMeasuring and enhancing retention and adherence in HIV prevention programmes
EPC330 Comparison of adherence measurement tools used in a pre-exposure prophylaxis demonstration study men who have sex with men in ChinaE-posterMeasuring and enhancing retention and adherence in HIV prevention programmes
EPC331 Accuracy of PrEP adherence measures among adolescents men who have sex with men and transgender women in BrazilE-posterMeasuring and enhancing retention and adherence in HIV prevention programmes
EPC332 Utilization of oral pre-exposure prophylaxis (PrEP) after FTC/TAF approval in the United States'E-posterMeasuring and enhancing retention and adherence in HIV prevention programmes
EPC333 Barriers and facilitators to daily, oral pre-exposure prophylaxis (PrEP) use among pregnant adolescent girls and young women (AGYW) in Cape Town, South Africa: A qualitative studyE-posterMeasuring and enhancing retention and adherence in HIV prevention programmes
PEMOC38 Adherence with antiretroviral therapy among recently pregnant HIV-positive women in 8 African countriesPoster exhibitionMeasuring and enhancing retention and adherence in HIV prevention programmes
PEMOC39 Effect of client profiling for tailored adherence support on ART retention among children and adolescents living with HIV/AIDS in an OVC program in NigeriaPoster exhibitionMeasuring and enhancing retention and adherence in HIV prevention programmes
PEMOC49 Strategies to support effective use of the vaginal ring and oral PrEP among adolescent girls and young women in sub-Saharan Africa: qualitative findings from MTN-034/REACHPoster exhibitionMeasuring and enhancing retention and adherence in HIV prevention programmes
EPB085 HIV status is associated with reduced risk for precancerous lesionsE-posterMalignancies (AIDS and non-AIDS)
971 - 980 of 2485 items